Max Robotics — Global Service Robot Directory + US Certification

About

Daniel E. Stange is a leading surgical oncologist whose research focuses on advancing minimally invasive techniques for esophageal cancer treatment, particularly through robotic-assisted surgery. His major contributions center on demonstrating the clinical superiority of robotic-assisted minimally invasive esophagectomy (RAMIE) over traditional open procedures. In his landmark prospective multicenter trial published in 2022, which has garnered 20 citations, Stange established standardized protocols for RAMIE using the da Vinci Xi system, showing its feasibility and safety across specialized centers. His propensity score-matched analysis, also from 2022 with 15 citations, revealed a groundbreaking finding: patients undergoing robotic esophagectomy experienced significantly reduced sarcopenia—muscle wasting—within the first postoperative year compared to those receiving open surgery, highlighting a key advantage in preserving patient strength and recovery. Stange’s work at a certified German center, documented in a 2021 study with 15 citations, further validated the strategic shift from open to robotic approaches, demonstrating reduced morbidity. Through these studies, Stange has positioned himself as a pivotal figure in esophageal surgery, providing robust evidence that robotic techniques not only improve surgical outcomes but also enhance long-term patient quality of life.